Management Of Thrombotic Thrombocytopenic Purpura

AABB Extracorporeal Therapy Committee (, 1992, Guidelines for Therapeutic Hemapheresis: 1992–3.

10.1056/NEJM197408222910802

10.1046/j.1365-2141.1996.d01-1902.x

10.1097/00005792-196603000-00003

10.7326/0003-4819-89-5-647

10.1177/000331978803900904

10.1016/0049-3848(85)90180-X

10.1002/(SICI)1098-1101(1998)13:3<133::AID-JCA7>3.0.CO;2-Z

10.1056/NEJM199108083250605

10.7326/0003-4819-128-7-199804010-00004

10.1111/j.1600-0609.1994.tb00649.x

Bobbio‐Pallavicini E., 1997, Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian Cooperative Group for TTP, Haematologica, 82, 429

10.1046/j.1526-0968.1999.00143.x

Burns E.R., 1982, Pathologic effects of plasma from patients with thrombotic thrombocytopenic purpura on platelets and cultured vascular endothelial cells, Blood, 60, 1030, 10.1182/blood.V60.4.1030.1030

10.1056/NEJM197712222972507

10.1002/ajh.2830340303

10.1002/jca.2920010204

10.1016/0140-6736(91)90801-U

10.1002/(SICI)1096-8652(199804)57:4<293::AID-AJH5>3.0.CO;2-P

10.1002/(SICI)1098-1101(1998)13:1<16::AID-JCA3>3.0.CO;2-C

10.7326/0003-4819-125-4-199608150-00006

Dang C.T., 1999, Enhanced endothelial cell apoptosis in splenic tissues of patients with thrombotic thrombocytopenic purpura, Blood, 93, 1264, 10.1182/blood.V93.4.1264

10.1073/pnas.87.16.6306

10.1002/(SICI)1096-8652(199601)51:1<1::AID-AJH1>3.0.CO;2-2

Fraser J.L., 1996, Possible association between the Norplant contraceptive system and thrombotic thrombocytopenic purpura, Obstetrics and Gynecology, 87, 860

10.1182/blood.V89.9.3097

10.1056/NEJM199811263392202

10.1055/s-0037-1614408

10.1002/(SICI)1096-8652(199706)55:2<55::AID-AJH1>3.0.CO;2-1

Galbusera M., 1999, Increased fragmentation of von Willebrand Factor, due to abnormal cleavage of the subunit, parallels disease activity in recurrent hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and discloses predisposition in families, Blood, 94, 610, 10.1182/blood.V94.2.610

Gerhard G.S., 1998, Coagulation parameters of ABO group‐specific cryosupernatant, American Journal of Clinical Pathology, 109, 379, 10.1093/ajcp/109.4.379

10.1002/jca.2920080407

10.1055/s-2007-994923

Gordon L.I., 1987, Deleterious effects of platelet transfusions and recovery thrombocytosis in patients with thrombotic microangiopathy, Seminars in Hematology, 24, 194

Harkness D.R., 1981, Hazard of platelet transfusion in thrombotic thrombocytopenic purpura, Journal of the American Medical Association, 246, 1931, 10.1001/jama.1981.03320170043028

10.1073/pnas.88.17.7844

Ishii Y., 1984, Case of thrombotic thrombocytopenic purpura. Successful treatment with ticlopidine, Japanese Journal of Clinical Hematology, 25, 1097

10.1016/S0140-6736(83)91795-6

10.1016/0002-9343(90)90470-X

Kwaan H.C., 1987, Miscellaneous secondary thrombotic microangiopathy, Seminars in Hematology, 24, 141

10.1016/S0140-6736(88)92287-8

Lian E.C.Y., 1991, Platelet agglutinating protein p37 causes platelet activation through its binding to membrane glycoprotein IV, Thrombosis and Haemostasis, 65, 102, 10.1055/s-0038-1647462

Mannucci P.M., 1989, Enhanced proteolysis of plasma von Willebrand factor in thrombotic thrombocytopenic purpura and the HUS, Blood, 74, 978, 10.1182/blood.V74.3.978.bloodjournal743978

10.1002/(SICI)1098-1101(1998)13:1<20::AID-JCA4>3.0.CO;2-B

Moake J., 1994, Solvent/detergent‐treated plasma suppresses shear‐induced platelet aggregation and prevents episodes of TTP, Blood, 84, 490, 10.1182/blood.V84.2.490.490

10.1056/NEJM198212023072306

10.1111/j.1365-2141.1990.tb06335.x

10.1001/jama.238.18.1944

Moschkowitz E., 1924, Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease, Proceedings of the New York Pathological Society, 24, 21

Murgo A.J., 1987, Thrombotic microangiopathy in the cancer patient including those induced by chemotherapeutic agents, Seminars in Hematology, 24, 161

Murphy W.G., 1987, Calcium‐dependent cysteine protease activity in the sera of patients with thrombotic thrombocytopenic purpura, Blood, 70, 1683, 10.1182/blood.V70.5.1683.1683

10.1097/00001721-199210000-00023

10.1016/S0049-0172(98)80023-1

10.1055/s-2007-1005113

10.1002/jca.2920100404

10.1002/(SICI)1096-8652(199801)57:1<57::AID-AJH10>3.0.CO;2-6

Porta C., 1999, Thrombotic thrombocytopenic purpura and autoimmunity: a tale of shadows and suspects, Haematologica, 84, 260

10.1016/S0140-6736(78)91573-8

10.1097/00005792-198111000-00003

10.1002/ajh.2830270306

10.1046/j.1537-2995.1992.32893032096.x

10.1111/j.1365-2141.1994.tb05131.x

10.1046/j.1365-2141.1996.d01-1800.x

10.1046/j.1365-2141.1998.01080.x

10.1056/NEJM199108083250604

10.1046/j.1365-2141.1998.01070.x

10.7326/0003-4819-122-8-199504150-00002

Siddiqui F.A., 1988, Platelet‐agglutinating protein p37 from a thrombotic thrombocytopenic purpura plasma forms a complex with human immunoglobulin G, Thrombosis and Haemostasis, 71, 299

10.1002/1097-0142(19930301)71:5<1882::AID-CNCR2820710527>3.0.CO;2-E

Sverlick R.A., 1992, Human dermal microvascular endothelial but not human umbilical vein endothelial cells express CD36 in vivo and in vitro, Journal of Immunology, 148, 78, 10.4049/jimmunol.148.1.78

10.1111/j.1365-2141.1994.tb05122.x

10.1016/S0140-6736(05)64019-6

10.1002/ajh.2830500203

10.1056/NEJM199811263392203

Tsai H.M., 1989, Multimers composition of endothelial cell‐derived von Willebrand factor, Blood, 73, 2074, 10.1182/blood.V73.8.2074.2074

10.1002/ajh.2830450407

10.1016/S0002-9610(99)80015-4